Cindy Jacobs
2022
In 2022, Cindy Jacobs earned a total compensation of $1.1M as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $159,250 |
---|---|
Option Awards | $233,135 |
Salary | $455,000 |
Stock Awards | $268,450 |
Total | $1,115,835 |
Jacobs received $455K in salary, accounting for 41% of the total pay in 2022.
Jacobs also received $159.3K in non-equity incentive plan, $233.1K in option awards and $268.5K in stock awards.
Rankings
In 2022, Cindy Jacobs' compensation ranked 2,812th out of 5,736 executives tracked by ExecPay. In other words, Jacobs earned more than 51.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,812 | 51st |
Manufacturing | 1,570 | 50th |
Chemicals And Allied Products | 729 | 49th |
Drugs | 681 | 48th |
In Vitro and In Vivo Diagnostic Substances | 13 | 55th |
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2022.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019